electroCore (ECOR) Stock Price, News & Analysis

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for electroCore in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ECOR shares.
View ECOR analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued twelve-month price targets for electroCore's shares. Their ECOR share price targets range from $10.00 to $10.00. On average, they anticipate the company's share price to reach $10.00 in the next year. This suggests a possible upside of 73.3% from the stock's current price.
View analysts price targets for ECOR or view top-rated stocks among Wall Street analysts.

electroCore's stock was trading at $5.95 on January 1st, 2024. Since then, ECOR stock has decreased by 3.0% and is now trading at $5.77.
View the best growth stocks for 2024 here.

electroCore saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 10,100 shares, a decrease of 40.6% from the March 15th total of 17,000 shares. Based on an average trading volume of 14,000 shares, the days-to-cover ratio is presently 0.7 days. Approximately 0.2% of the shares of the stock are sold short.
View electroCore's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our ECOR earnings forecast.

electroCore, Inc. (NASDAQ:ECOR) posted its quarterly earnings data on Wednesday, March, 13th. The company reported ($0.61) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by $0.06. The company earned $5.19 million during the quarter, compared to analyst estimates of $5.23 million. electroCore had a negative net margin of 117.49% and a negative trailing twelve-month return on equity of 201.47%. During the same period in the previous year, the business posted ($1.22) EPS.

Shares of electroCore reverse split before market open on Tuesday, February 14th 2023. The 1-15 reverse split was announced on Tuesday, February 14th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other electroCore investors own include T2 Biosystems (TTOO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Bionano Genomics (BNGO), Matinas BioPharma (MTNB), Acasti Pharma (ACST), Onconova Therapeutics (ONTX) and OPKO Health (OPK).

electroCore (ECOR) raised $64 million in an IPO on Friday, June 22nd 2018. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. Evercore ISI and JMP Securities acted as the underwriters for the IPO and BTIG was co-manager.

electroCore's stock is owned by a number of retail and institutional investors. Top institutional investors include International Assets Investment Management LLC (0.88%). Insiders that own company stock include Brian M Posner, Daniel S Goldberger, John P Gandolfo, Joseph P Errico, Thomas J Errico, Thomas J Errico and Trevor J Moody.
View institutional ownership trends.

Shares of ECOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.